Delivery Order SPE2DB22D2206-SPE2DB24FGU56
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $3,239.99 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, to provide 4566054689 DROXIDOPA 200 MG CAPSULE 90S. This contract has an ultimate completion date of October 9, 2024 and is not set aside for a specific socioeconomic program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
- This federal contract award is for the delivery of 4,564,741,740 units of the pharmaceutical product Droxidopa 100 mg capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for a ceiling value of $7,021.56. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation....
- The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,125.98 firm fixed-price delivery order is for the supply of DROXIDOPA 100 MG CAPSULE 90S, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4,564,528,640 units of the pharmaceutical product Droxidopa 100 mg Capsule. The contract, valued at $36,956.64, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) and has a completion date of May 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen, a major pharmaceutical distribution company, leverages its...
- This federal contract award, identified as SPE2DB25D3018|SPE2DB25FUXMP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,236,364 units of DROXIDOPA 300 MG CAPSULE 90S, a medication, with a ceiling value of $28,310.61. The contract is a firm fixed-price arrangement with a period of performance extending to May 14, 2025. Amerisourcebergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of 4,564,463,038 units of droxidopa 200 mg capsules, with a ceiling value of $6,776.80 and a completion date of April 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This federal contract award, with ID SPE2DB20D3303|SPE2DB25FY8J9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,008.41 firm fixed-price delivery order contract is for the supply of 4566929688 - DROXIDOPA 300 MG CAPSULE 90S. The ultimate completion date for this contract is January 15, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor...
- This federal contract award, valued at $2,793.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567110760 - DROXIDOPA 200 MG CAPSULE 90S, with an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $4,030.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,115,953 units of the prescription medication droxidopa 100 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 5, 2025. It is not designated as a set-aside contract, indicating open...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,601.10 firm fixed price delivery order is for the provision of 4,564,256,138 capsules of the pharmaceutical drug Droxidopa 100 mg. The award has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is part of a larger indefinite delivery...